Di-genic inheritance of germline POLE and PMS2 pathogenic variants causes a unique condition associated with pediatric cancer predisposition.
Orli MichaeliHagay LadanyAyelet ErezShay Ben ShacharShai IzraeliGabriel LidzbarskyLina Basel-SalmonSaskia BiskupYosef E MaruvkaHelen ToledanoYael GoldbergPublished in: Clinical genetics (2022)
Polymerase proofreading-associated polyposis (PPAP) and Lynch syndrome, caused by mutated POLE and mismatch repair (MMR) genes, respectively, are associated with adult-onset cancer. PPAP and MMR-deficient tumors are both hypermutated, and each has a unique mutational signature. We describe a 4.5-year-old boy with multiple café au lait spots who presented with metastatic Sonic Hedgehog-activated medulloblastoma, with partial response to intensive chemotherapy and immunotherapy. The tumor showed microsatellite stability, loss of PMS2 nuclear expression, and an exceptionally high tumor mutational burden of 276 Mut/Mb. Germline molecular analysis revealed an inherited heterozygous pathogenic POLE variant and a de novo heterozygous PMS2 pathogenic variant. The tumor featured the MMR, POLE, and POLE+MMR mutational signatures. This is the first description of a di-genic condition, which we named "POL-LYNCH syndrome," manifested by an aggressive ultra-mutant pediatric medulloblastoma with a unique genomic signature.
Keyphrases
- papillary thyroid
- squamous cell
- early onset
- copy number
- genome wide
- squamous cell carcinoma
- poor prognosis
- high resolution
- mitochondrial dna
- case report
- wild type
- lymph node metastasis
- gene expression
- young adults
- oxidative stress
- radiation therapy
- transcription factor
- locally advanced
- dna damage
- single cell
- biofilm formation
- staphylococcus aureus
- gold nanoparticles
- genetic diversity
- candida albicans